The Food and Drug Administration has launched a cloud-based portal enabling researchers to work together to improve the quality and accuracy of next-generation sequencing (NGS) genomic tests, which compile a vast amount of data on a person’s exact sequence of DNA.

Tuesday’s beta launch of the collaborative platform—precisionFDA—is being described as a “research sandbox” for the genomics community where scientists and test developers can explore NGS methodologies to develop necessary standards for the testing technology that quickly sequences a person’s genome to detect and interpret genetic variants.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access